PCM
PROF icon

Perkins Capital Management’s Profound Medical PROF Stock Holding History

Perkins Capital Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$760K Hold
114,280
– – 0.57% 41
2026
Q1 		$741K Hold
114,280
– – 0.69% 43
2025
Q4 		$899K Buy
+114,280
New +$734K 0.71% 43

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Perkins Capital Management's PROF Position: Q2 2026 in Review

Perkins Capital Management held its Profound Medical (PROF) position steady in Q2 2026 at 114,280 shares worth $760K. The position accounts for 0.57% of the portfolio, ranked #41.

Perkins Capital Management first reported a position in PROF in Q4 2025 and has held it in 3 quarters since. The position peaked at $899K in Q4 2025. 55 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Perkins Capital Management held 114,280 shares of Profound Medical worth $760K as of Q2 2026.
  • Perkins Capital Management left its Profound Medical share count unchanged in Q2 2026.
  • Profound Medical made up 0.57% of Perkins Capital Management's portfolio in Q2 2026, its #41 holding.
  • Perkins Capital Management first reported a position in Profound Medical in Q4 2025 and has held it in 3 quarters since.
  • Perkins Capital Management's Profound Medical position peaked at $899K in Q4 2025.
  • 55 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.